Mendoza, Renalyn G.
HRN: 07-75-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2023
METRONIDAZOLE 500MG (TAB)
01/18/2023
01/25/2023
PO
500mg
BID X 7 Days
PPROM X 1 Week; Oligohydramnios; Bacterial Vaginosis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes